Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variants in the leptin-MC4R pathway and ciliopathy-related genes in youths with obesity beyond hyperphagia and early onset.

Journal of endocrinological investigation·2026
Same author

Bone Mineral Density in Hemophilia and VWD.

Blood advances·2026
Same author

fNIRS estimates prefrontal cortex activation following glucose load in youths with obesity.

Journal of endocrinological investigation·2026
Same author

Sleeve Gastrectomy in Paediatric and Transition Age Patients with Prader-Willi Syndrome: A 5-Year Longitudinal Study.

The Journal of clinical endocrinology and metabolism·2026
Same author

Screening practices for diabetic peripheral neuropathy in pediatric type 1 diabetes: a nationwide survey by the ISPED Diabetes Study Group.

Acta diabetologica·2026
Same author

Inhibition of endolysosomal two-pore channel 2 (TPC2) induces osteoblast differentiation and matrix mineralization while targeting autophagy.

Journal of endocrinological investigation·2026

Related Experiment Video

Updated: Mar 16, 2026

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.2K

New Perspectives in Glioblastoma: Nanoparticles-based Approaches.

Rosa Luciano, Giulia Battafarano, Rossana Saracino

  • 1Multi-Factorial Disease and Complex Phenotype Research Area, Bambino Gesu Children's Hospital, IRCCS, Viale di San Paolo 15, 00146, Rome, Italy.

Current Cancer Drug Targets
|August 17, 2016
PubMed
Summary

Nanomedicine using nanoparticles and extracellular vesicles shows promise for treating aggressive glioblastoma (brain cancer). This innovative approach offers a more effective and specific glioma treatment with fewer side effects than traditional methods.

Keywords:
Glioblastomaextracellular vesiclesnanomedicinenanoparticles

More Related Videos

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
07:25

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Published on: March 1, 2024

3.2K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

8.4K

Related Experiment Videos

Last Updated: Mar 16, 2026

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.2K
Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
07:25

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Published on: March 1, 2024

3.2K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

8.4K

Area of Science:

  • Oncology
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Glioblastoma multiforme is an aggressive central nervous system tumor with a poor prognosis.
  • Current treatments (surgery, radiation, chemotherapy) are rarely curative.
  • Nanomedicine offers innovative diagnostic and therapeutic advantages across various diseases.

Purpose of the Study:

  • To review the application of nanoparticles and extracellular vesicles in glioblastoma treatment.
  • To highlight the efficacy and specificity of nanomedicine for glioma.
  • To assess the potential for reducing side effects compared to conventional therapies.

Main Methods:

  • Literature review of studies on nanoparticles in glioblastoma.
  • Analysis of research on extracellular vesicles for glioma therapy.
  • Synthesis of findings on efficacy, specificity, and side effect profiles.

Main Results:

  • Nanoparticles and extracellular vesicles demonstrate significant potential in glioblastoma treatment.
  • These nanomedicine approaches show high efficacy and specificity for glioma.
  • Reduced side effects compared to conventional therapies are a key advantage.

Conclusions:

  • Nanomedicine, particularly using nanoparticles and extracellular vesicles, represents a promising therapeutic strategy for glioblastoma.
  • Further research is warranted to optimize these nanomedicine approaches for clinical application.
  • This field holds potential for improving outcomes in aggressive brain tumor treatment.